Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

May 31, 2008

Conditions
Cesarean SectionAnesthesia,SpinalPostoperative Nausea and Vomiting
Interventions
DRUG

Bupivacaine

12.5 mg of a 5 mg/ml hyperbaric solution, intrathecally

DRUG

Morphine

200 µg of a 200 µg/ml solution, intrathecally

DRUG

Isotonic saline solution

"0.9% NaCl solution~0.1 ml, intrathecally in group Control and IV Atropine~0.1 ml, intravenously in group Control and Intrathecal Atropine"

DRUG

Atropine

"100 µg of a 1 mg/ml preservative-free solution~* intrathecally in group Intrathecal Atropine~* intravenously in group IV Atropine"

Trial Locations (2)

43126

University and Hospital of Parma (Azienda Ospedaliero-Universitaria di Parma), Parma

98122

University of Messina, Messina

All Listed Sponsors
lead

University of Parma

OTHER

NCT00921102 - Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section | Biotech Hunter | Biotech Hunter